Related by context. All words. (Click for frequent words.) 83 pralatrexate injection folate analogue 79 Personalized Immunotherapy 78 Initiates Enrollment 78 Initiates Phase II 78 Pivotal Phase III 77 product platforms AZX# 77 refractory chronic lymphocytic 77 Completes Patient Enrollment 77 PDX pralatrexate 77 Phase 2b Clinical Trial 76 pralatrexate injection 76 IL# PE#QQR 76 Initiates Clinical Trial 76 Elagolix 76 Presents Positive 76 methylnaltrexone bromide 76 Receives Orphan Drug Designation 76 lucinactant 76 Presents Preclinical 76 Therapeutic Competitors Companies 76 sorafenib tablets 76 phase IIb clinical 75 virus HCV protease inhibitor 75 tiapamil 75 Evoltra ® 75 Phase #b/#a clinical 75 oral prodrug 75 Phase III Clinical Trial 75 Tezampanel 75 TRANSDUR ™ 75 Announces Poster Presentations 75 Panzem R 75 Initiates Clinical 75 Initiate Clinical Trial 75 Begins Dosing 75 MyVax R 75 Meets Primary Endpoint 75 VIVITROL ® 75 CYT# potent vascular disrupting 75 investigational pan BCR 74 Sapacitabine 74 MEK Inhibitor 74 Patient Enrollment 74 ELADUR ™ 74 Presents Preclinical Data 74 ALN PCS 74 investigational humanized monoclonal antibody 74 INSPIRE Trial Phase III 74 Oracea TM 74 Civacir 74 Xcytrin R 74 Therapeutic Competitors companiesandmarkets.com adEgemonye 74 Hsp# Inhibitor 74 MOVIPREP R 74 induced macular edema 74 Initiates Phase III 74 non nucleoside inhibitor 74 phase IIb trial 74 ThermoDox R 74 R Saizen R 74 TRANSDUR ® 74 ospemifene 74 Combination REOLYSIN R 74 Reports Preclinical Data 74 Friedreich Ataxia FRDA 74 Initiate Phase 74 FUSILEV ® 74 dihydrochloride Tablets 74 Immunotherapeutic 74 2 methoxyestradiol 74 sodium thiosulfate STS 74 mertansine 74 Phase IIb Clinical Trial 74 PNP inhibitor 74 acetonide FA 74 Daclizumab 74 targeted radiotherapeutic 74 Achieves Primary Endpoint 74 Romidepsin 73 Celsion Corporation 73 Cetrorelix 73 rasagiline tablets 73 elotuzumab 73 Archexin 73 Solazed TM 73 derivatives Radilex TM 73 MAGE A3 ASCI 73 Telik logo TELINTRA 73 cetuximab Erbitux R 73 Glatiramer Acetate 73 GTC recombinant human 73 interferon gamma 1b 73 Receives Orphan Drug 73 investigational monoclonal antibody 73 Pivotal Trial 73 LibiGel ® 73 BENLYSTA ® 73 phase III isavuconazole 73 MKC# MT 73 Granted Orphan Drug 73 evaluating tivozanib 73 PHX# 73 AAG geldanamycin analog 73 Inc. AMEX YMI 73 mesylate tablets 73 Aflibercept 73 alvespimycin 73 Phase Ib II 73 oral proteasome inhibitor 73 forodesine 73 Entereg R 73 investigational antiplatelet agent 73 Azedra 73 ThermoDox ® clinical 73 markets HP Acthar 73 personalized cellular immunotherapy 73 lexidronam injection 73 NDA Submission 73 XL# anticancer compounds 73 OTCBB PYTO 73 Annamycin 73 hypoxia activated prodrug 73 Aviptadil 73 Panzem R NCD 73 Augment TM 73 Pivotal Phase 73 www.ucb group.com 73 novel VDA molecule 73 Pegloticase 73 Phase Ib clinical 73 Iluvien ® 73 Zorbtive TM 73 toenail onychomycosis 73 ZEVALIN ® 73 SYCREST 73 Phase 2b Trial 73 JAK inhibitor 73 ALN HPN 73 vapreotide acetate 72 dependent kinase inhibitor 72 oncolytic virus therapies 72 samarium Sm 72 TLK# 72 GATTEX TM 72 kidney urologic 72 systemic anaplastic large 72 Rhucin ® recombinant 72 diarrhea predominant irritable 72 Pafuramidine 72 liposomal formulation 72 Ridaforolimus 72 Safinamide 72 Receives Approvable Letter 72 hyperphenylalaninemia HPA due 72 miconazole Lauriad ® 72 CINTREDEKIN BESUDOTOX 72 JAK2 Inhibitor 72 lintuzumab SGN 72 XL# XL# 72 topically applied SEPA 72 MKC# MKC# PP 72 Cellegesic 72 Soliris eculizumab 72 Homspera TM 72 R sorafenib tablets 72 Files IND 72 candidate CRLX# 72 NASDAQ AVNR 72 Vicriviroc 72 adecatumumab MT# 72 IgG1 monoclonal antibody 72 Preclinical Data 72 Phase 2a Trial 72 Cloretazine 72 Disease IBD 72 rusalatide acetate 72 trastuzumab DM1 T DM1 72 OTCBB OHRP 72 VISICOL R 72 Prodarsan R 72 Nasdaq HALO 72 LymphoStat B TM 72 POSIDUR TM ELADUR TM 72 Phase IIb Trial 72 pan HDAC inhibitor 72 Amrubicin 72 histone deacetylase HDAC inhibitor 72 IMiDs R 72 Exherin TM 72 Kuvan TM sapropterin 72 Nasdaq XTLB 72 generation purine nucleoside 72 Submits NDA 72 candidates Azedra TM 72 Brentuximab Vedotin SGN 72 TELINTRA 72 Telavancin 72 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 72 TO AVOID PREGNANCY WHILE 72 receptor tyrosine kinase inhibitor 72 oral JAK#/JAK# inhibitor 72 Presents Positive Preclinical 72 Clinical Trial Results 72 Phase III Pivotal 72 Inhalation Solution 72 PEG SN# 72 oral ridaforolimus 72 Vitrasert R 72 Phase 2a Clinical Trial 72 Liprotamase 72 Romiplostim 72 CEQ# 72 molecular imaging radiopharmaceutical 72 Kosan dependence 72 IMiDs ® compound 72 Drug Candidate 72 recurrent metastatic ovarian cancer 72 phase Ib clinical 72 Cleviprex TM clevidipine 72 selective androgen receptor modulators 72 SNT MC# 72 Novel Oral 72 vaginally administered lidocaine 72 PROSTASCINT R 72 huC# DM4 72 Crofelemer budesonide foam 72 Fludara ® 72 Hedgehog Pathway Inhibitor 72 FDA APPROVES 72 FDA Accepts 72 anticancer compound 72 NYSE Amex PTN 72 candidate AQ4N 72 Ambrisentan 72 COLAZAL R 71 Ozarelix 71 YONDELIS 71 Nasdaq OPTR 71 ALN TTR 71 Nasdaq DVAX 71 Phase Ib IIa 71 R lenalidomide 71 Apaziquone 71 TKB# 71 XL# XL# XL# 71 R roscovitine CDK cyclin 71 IMiDs 71 Epratuzumab 71 OvaRex ® MAb 71 Omacetaxine 71 Pirfenidone 71 IMA# 71 docetaxel Taxotere R 71 CRMD# 71 peptidic compound 71 FACTIVE R gemifloxacin 71 Initiates Phase 2b 71 multicenter Phase III 71 erlotinib Tarceva ® 71 Myocet 71 dasatinib Sprycel ® 71 Metastatic Melanoma 71 Successfully Completes Phase 71 including eniluracil ADH 71 octreotide implant 71 refractory gout 71 cutaneous T 71 small molecule thrombopoietin 71 Cloretazine ® 71 Aryplase 71 IAP inhibitors 71 Phase IIb clinical trials 71 Randomized Phase 71 selective androgen receptor modulator 71 PrevOnco 71 acyclovir Lauriad R 71 monoclonal antibody conjugated 71 Æterna Zentaris Inc. 71 Receives Fast Track 71 HGS# 71 Inhalation Aerosol 71 Mylan Receives Approval 71 multicenter Phase II 71 Phase IIIb clinical 71 Completes Enrollment 71 Ceflatonin R 71 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 71 SPRYCEL ® 71 PI3K/Akt pathway inhibitor 71 Gel repository corticotropin injection 71 mGluR5 negative 71 Zemiva TM 71 Luveris R Ovidrel R 71 Zenvia ™ 71 novel histone deacetylase 71 Kuvan R 71 CD3 monoclonal antibody 71 Inc Therapeutic Competitors 71 humanized anti 71 interferon beta 1a infertility 71 Genasense ® oblimersen 71 KRN# 71 Glufosfamide 71 telomerase therapeutic 71 nasal calcitonin product 71 Receives Milestone Payment 71 LymphoStat B belimumab 71 novel emulsion formulation 71 relapsed multiple myeloma 71 Squalamine 71 L BLP# 71 Alinia 71 R#/MEM 71 Genaera Corporation 71 Ixempra 71 First Patient Enrolled 71 Phase III Trial 71 AKIP ™ 71 CR# vcMMAE 71 Orapred ODT 71 HCl PEPCID ® famotidine 71 Saizen ® 71 Phase Ib clinical trials 71 selective immunoproteasome inhibitor 71 OTCBB QTXB 71 Nasdaq PGNX 71 Nasdaq SNSS 71 rALLy clinical trial 71 candidate XP# 71 candidate deforolimus 71 Phase 1b trial 71 LEP ETU 71 Initiates Phase 71 corticotropin injection 71 II Clinical Trial 71 apricitabine ATC 71 Agonist MABA program 71 SUPPRELIN R LA 71 sarcoma melanoma 71 Protalex Inc. 71 treat male hypogonadism 71 StaphVAX R 71 MEK inhibitor 71 Deforolimus 71 Onalta 71 Nasdaq RDEA 71 isoform selective 71 BARACLUDE R 71 By JAMAAL ABDUL 71 Oral Fingolimod 71 dextromethorphan quinidine 71 Enzyme Replacement Therapy 71 Panzem NCD 71 Phase 1b clinical trials 71 Investigational Treatment 71 Dacogen injection 71 Deferiprone 71 novel synthetic PEGylated 71 commercializing anti infective 71 CD# CEA 71 NASDAQ CLSN 71 compound PMX # 71 BiovaxID TM 71 Gamunex C 71 Ovitrelle R Serostim 71 Files Investigational 71 Lupus Nephritis 71 hoFH 71 Pharmion Corporation 70 thetreatment 70 RECOTHROM R 70 Alzheimer disease cognitive impairment 70 sapropterin dihydrochloride 70 Familial Adenomatous Polyposis FAP 70 AEG# 70 ularitide 70 metastatic castrate resistant 70 Anturol TM 70 histamine dihydrochloride 70 Advanced Renal Cell 70 Phase Ib study 70 phase IIa clinical 70 PDE4 inhibitor 70 Prestara TM 70 Nasdaq IDRA 70 OTCQB CTIX 70 TBC# 70 Nasdaq VNDA 70 delivers fluocinolone acetonide FA 70 Veregen TM 70 CTAP# Capsules 70 Pivotal Clinical Trial 70 Vion Pharmaceuticals 70 YONDELIS R 70 Investigational Compound 70 hyaluronidase enzyme 70 Navelbine ® 70 initiated Phase 1b 70 orally administered inhibitor 70 Study Evaluating 70 cell lymphoma CTCL 70 Solazed ™ 70 Oral Calcitonin 70 Vidaza azacitidine 70 PKC# 70 please visit http:/www.vandapharma.com 70 NASDAQ ALTH 70 Therapeutic Competitors 70 Allovectin 7 70 registrational 70 non nucleoside HCV 70 Raptiva R 70 HDAC Inhibitor 70 Fast Track Status 70 Hepatocellular Carcinoma 70 Recombinant Human 70 Pralatrexate 70 QUADRAMET R 70 Pivotal Study 70 Manja Bouman CEO 70 AKT inhibitor 70 GVAX ® 70 REGENERX BIOPHARMACEUTICALS INC. 70 NasdaqGM SPPI 70 rxRNA 70 reslizumab 70 Tesetaxel 70 Nasdaq NPSP 70 herpetic keratitis 70 PEGylated anti 70 OTCBB CVBT 70 orally inhaled migraine 70 Vaccine Adjuvant 70 vaccine GRNVAC1 70 Virulizin ® 70 Aurexis 70 modified glutathione analog 70 ARIKACE ™ 70 Topline Results 70 Neulasta R 70 DIFICID ™ 70 midstage clinical 70 Panzem 70 By JENNIFER LEARN 70 OMNARIS HFA 70 Vidaza R 70 Complicated Skin 70 Idera Pharmaceuticals 70 Golimumab 70 TNF Tumor Necrosis Factor 70 PROGENSA R 70 AMITIZA R 70 Completes Patient Enrolment 70 PANVAC VF 70 NASDAQ OPTR 70 Nasdaq PPHM 70 PEGylated Fab fragment 70 candidates Azedra 70 NASDAQ SNTA 70 RELOVAIR ™ 70 NYSE Amex PBTH 70 HepeX B TM 70 Entereg TM 70 Elotuzumab 70 human C1 inhibitor 70 Phase III Clinical Trials 70 Ecallantide 70 StromaCel Inc. 70 Lubiprostone 70 Microplasmin 70 Nasdaq IDIX 70 platinum chemotherapeutic 70 Cinryze ™ 70 antibody MAb 70 brand ciclesonide HFA 70 MOZOBIL 70 Nasdaq EPCT 70 TRACON Pharmaceuticals 70 Syncria R 70 Dapagliflozin 70 Nexavar ® 70 Nasdaq NRGN 70 CCR9 antagonist 70 essential thrombocythemia ET 70 relapsed refractory multiple myeloma 70 Nexavar sorafenib 70 pan histone deacetylase 70 Silodosin 70 HGS ETR2 70 First Patient Dosed 70 BioNumerik 70 thalidomide Thalomid 70 vidofludimus 70 EVIZON TM 70 ELADUR TM 70 Intravenous CP 70 Bucindolol 70 Bazedoxifene 70 ARRY # 70 refractory cutaneous T 70 VitiGam 70 Wafer polifeprosan 70 THR beta agonist 70 Modrenal R 70 Testosterone MDTS ® 70 HuLuc# 70 gastro intestinal inflammation 70 VEGFR2 inhibitor 70 Targanta Therapeutics Corporation 70 seliciclib CYC# 70 Inc. NASDAQ AEZS 70 Phase IIa Clinical Trial 70 Nasdaq VRTX today 70 mitogen activated ERK kinase 70 adenosine injection 70 CRMD pharmaceutical 70 NUEDEXTA ™ 70 Intravenous Human 70 Initiates Clinical Trials 70 Granulocyte Colony Stimulating Factor 70 ALTROPANE R 70 Peginterferon alfa 2b 70 Icatibant 70 Methylnaltrexone 70 Alocrest 70 Vidaza ® 70 visit www.genenews.com 70 aerosolized AAT 70 CYCLOSET ® 70 OTCBB VCRT 70 LHRH antagonists 70 novel therapeutic antibodies 70 Denufosol 70 metabolic inhibitor 70 Degarelix 70 pharmacokinetic PK study 70 Fx #A 70 Demonstrates Positive 70 Nitazoxanide 70 Phase 1b Clinical Trial 70 OMNARIS Nasal Spray 70 5 HT3 antagonist 70 IMiDs ® 70 documented candidiasis 70 Fabry Disease 70 sodium Injection 70 SPL# Gel vaginal microbicide 70 evaluating satraplatin 70 radiation sensitizer 70 Serostim ® 70 Allovectin 7 r 70 MT# MEDI 70 TYZEKA 70 Nasdaq PARD 70 ALN TTR# 70 AVASTIN 70 Sirolimus eluting Coronary Stent 70 etanercept Enbrel 70 SARMs 69 JOULFERON 69 developing Bicifadine serotonin 69 Opterone R 69 ONCONASE R 69 Prestara 69 Phase 2b Study 69 Aplidin R 69 Anidulafungin 69 NASDAQ LGND 69 Commences Phase 69 Brussels THR 69 Cutaneous T 69 OTCBB IMUC 69 AMEX RGN 69 Actimmune ® 69 Perifosine 69 registrational trial 69 leading oral taxane 69 Kamada AAT 69 bevacizumab Avastin R 69 LEUKINE 69 Pulmonary Arterial Hypertension 69 Patients Treated With 69 label Lipofen R 69 HuMax TAC 69 mapatumumab 69 intravesical infusion therapy 69 NEBIDO R 69 Interferon beta 1a 69 Etubics 69 initiated Phase Ib 69 Systemic Delivery 69 Pazopanib 69 topical non steroidal 69 JAK2 inhibitor 69 Nasdaq ALTH 69 telomerase inhibitor drug 69 Eluting Coronary Stent System 69 ferumoxytol Injection 69 Neulasta ® 69 FDA Approvable Letter 69 AVONEX ® 69 ZADAXIN ® 69 visit http:/www.mannkindcorp.com 69 oral salmon calcitonin 69 BRIM2 69 Phase #b/#a 69 AzaSite Xtra 69 Locteron ® 69 Blinatumomab 69 ulimorelin 69 Submits Response 69 Gonal f R 69 Curaxin CBLC# 69 Tanespimycin 69 Teplizumab 69 Diabetic Macular Edema DME 69 TAXUS Element Paclitaxel Eluting 69 oral ghrelin agonist 69 ChemGenex Pharmaceuticals Limited 69 EOquin TM 69 Rebif ® 69 GATTEX ® 69 NasdaqCM PSTI DAX PJT 69 dihydrochloride 69 Zenvia Phase III 69 Prospective Randomized 69 prokinetic agent 69 Virulizin R 69 Temsirolimus 69 Aplidin 69 Plicera 69 Clolar ® 69 INS# [001] 69 RANK Ligand inhibitor 69 R bendamustine hydrochloride 69 Selective Electrochemical Tumor Ablation 69 OvaRex R 69 Raptiva ® 69 2 inhibitor CYT# 69 HP Acthar Gel repository 69 IV Busulfex 69 Diabetic Macular Edema 69 Zemiva ™ 69 torezolid phosphate 69 Phase 2a Study 69 HuMax HepC TM 69 ongoing Phase 1b 69 Frozen Shoulder syndrome Adhesive 69 Quinamed 69 FOLFOX6 chemotherapy regimen 69 TELINTRA R 69 AzaSite Plus 69 Inc. Nasdaq IMGN 69 Trodusquemine MSI 69 Bicifadine 69 Phase 2b clinical 69 Calcium Acetate 69 ODT metoclopramide HCl PEPCID 69 NASDAQ INGN 69 RNAi Therapeutic 69 phase IIb 69 relapsed leukemia 69 SinuNase TM 69 severe hypercholesterolemia 69 Mg Usa 69 dasatinib Sprycel 69 HuCAL GOLD R 69 individualized cellular immunotherapy 69 Injectable Suspension 69 sunitinib malate 69 R roscovitine 69 ADP receptor antagonist 69 ImmuneRegen BioSciences Inc. 69 MBRX 69 NuMimetic TM 69 BEMA Granisetron 69 Azacitidine 69 NASDAQ AEZS 69 Adjuvant Treatment 69 AFREZZA TM 69 catheter occlusion 69 GNSZ 69 Spiegelmer ® 69 Advanced Melanoma 69 Elvitegravir 69 Nasdaq CYCC 69 include PLX IBD 69 Vaprisol 69 Bioral Amphotericin B 69 Xeloda ® 69 Nasdaq CYTR biopharmaceutical 69 DOS# 69 Vicinium TM 69 acne impetigo 69 P#X# antagonist 69 IND Filing 69 Veronate R 69 Nanobody 69 Dose Ranging Study 69 Nasdaq IMGN 69 Xanafide 69 sodium glucose cotransporter 69 HCV NS5B polymerase 69 gastrointestinal disorders ATI 69 THALOMID 69 humanized monoclonal 69 CCR5 mAb 69 Mycophenolate Mofetil 69 glucokinase activator 69 MelaFind R 69 Pyridorin 69 NasdaqGM NTEC today 69 AMEX REX 69 Nasdaq VRTX 69 subsidiaries visit http:/www.apricusbio.com 69 Advancing Drugs 69 DURECT proprietary 69 KRYSTEXXA TM pegloticase 69 Phase 1a clinical 69 TRO# 69 Sanvar R 69 recombinant biopharmaceutical 69 Factor VIIa 69 RELISTOR ® 69 ABL inhibitor 69 ATL# [001] 69 opioid induced bowel dysfunction 69 Soliris TM eculizumab 69 Luteinizing Hormone Releasing Hormone 69 Chemokine Therapeutics 69 Prochymal TM 69 NASDAQ PCYC 69 AEGR 69 ALVESCO ® 69 Completes Dosing 69 OTCBB IMNR 69 systemic RNAi therapeutic 69 Proxinium TM 69 alfa 2a 69 Present Preclinical Data 69 KNS # 69 volociximab 69 Prostate AdenoCarcinoma Treatment 69 nitric oxide donating prostaglandin 69 Vandetanib 69 SAR# [004] 69 EP #R 69 investigational pharmacologically unique 69 Prolongs Survival 69 PROLOR Biotech Inc. 69 BYETTA ® 69 nasal decolonization 69 panitumumab Vectibix 69 proteasome inhibitor 69 anti infective treatments 69 selective kinase inhibitor 69 Dalbavancin 69 JZP 69 Severe Sepsis 69 Allovectin 7 R 69 SinuNase ™ 69 Eltrombopag 69 Trial Evaluating 69 Tibotec BVBA 69 Nasdaq IDRA today 69 familial amyloidotic polyneuropathy FAP 69 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 69 GTC recombinant form 69 ATRA IV 69 Randomized Phase II 69 cancer neuroendocrine tumor 69 docetaxel Taxotere ® 69 DRRX 69 balsalazide tablet 69 OMP #R# 69 Orally administered 69 cinacalcet HCl 69 R MSCRAMM 69 NYSE Amex YMI 69 Besivance 69 Phenoptin 69 EVIZON TM squalamine lactate 69 OTCQX QRXPY 69 Viprovex TM 69 oral Janus kinase 69 mocetinostat MGCD# 69 Aganocide 69 Onco TCS 69 liver resection surgeries 69 Catena ® 69 dermatology therapies 69 LSE ASM 69 Serostim R 69 REPRONEX R menotropins 69 oxypurinol 69 metaglidasen 69 peginesatide 69 Onalta ™ 69 PLK1 SNALP 69 FavId 69 bevacizumab Avastin ® 69 oral nucleoside analogue 69 velafermin belinostat 69 Avila Therapeutics 69 TSX CTI 69 Inc. ProMetic www.prometic.com 69 Preclinical Study 69 Cardium Therapeutics TM 69 vascular disrupting agent 69 Insegia 69 castrate resistant prostate cancer 69 teduglutide 69 metastatic castration resistant 69 Initiates Dosing 69 Lispro 69 Albugon 69 oral deforolimus 69 Oral Formulation 69 Davunetide 69 Xyfid TM 69 IAP inhibitor 69 Unit Dose Budesonide 69 NASDAQ OGXI 69 EDEMA3 69 trastuzumab DM1 69 PRTX 69 OTCBB HNAB 69 Clofarabine 69 oral Azacitidine 68 midstage trials 68 vaccines oncolytic virus 68 ABILIFY ® 68 tubulin inhibitor 68 REVLIMID lenalidomide 68 Announces Tentative Approval 68 Oral Suspension Oral Suspension 68 Nasdaq IDIX biopharmaceutical 68 Commence Phase 68 cardiometabolic diseases Glucophage 68 ArQule Kinase Inhibitor Platform 68 DELATESTRYL R 68 investigational oral inhibitor 68 R metformin Concor 68 OTC BB PVCT 68 including thyroiditis RA 68 Inc. Nasdaq CYCC 68 Cethrin R 68 HuCAL PLATINUM ® CysDisplay 68 NASDAQ CYTK announced 68 arsenic trioxide injection 68 galiximab 68 Exherin 68 Testim R 68 4SC AG ISIN DE# 68 NASDAQ CXSP announced 68 retinal vein occlusion induced 68 myeloproliferative disorders 68 omacetaxine mepesuccinate 68 Pyridorin TM 68 cetuximab Erbitux 68 Onalta TM 68 XIAFLEX ® 68 NASDAQ ABII 68 Genotyping Test 68 Phase 1b clinical 68 Atiprimod 68 pentadentate logo R 68 oropharyngeal candidiasis OPC 68 AVE# 68 Auxilium Pharma 68 selective modulator 68 cardio renal 68 omega interferon 68 ZACTIMA 68 evaluating picoplatin 68 BiTE R 68 DermaVir Patch 68 RenaZorb TM 68 sapropterin dihydrochloride Tablets 68 oral beclomethasone dipropionate 68 complement inhibitor eculizumab 68 nucleoside analog 68 myelodysplastic myeloproliferative diseases 68 NS5b 68 #D#C# 68 Genasense ® 68 LEVADEX ™ 68 Epeius Biotechnologies Corporation 68 Licenses Novel 68 HepeX B 68 Nasdaq ENZN 68 Corlux 68 RNAi Therapeutics 68 programs visit http:/www.bionovo.com 68 OncoVex 68 Proellex TM 68 Levoleucovorin 68 PXD# 68 BRIM3 68 Potelligent Technology 68 Patient Enrolment 68 Onconase 68 DOXIL R 68 MEK inhibitor RDEA# 68 GTC NASDAQ GTCB 68 highly purified pasteurized 68 AQ4N 68 sapacitabine CYC# 68 OTCBB INSV 68 Bioral ® 68 targeting CD# 68 Adenoscan R 68 PREOS R 68 transthyretin mediated amyloidosis ATTR 68 NASDAQ SHPGY 68 CB2 selective receptor agonist 68 Aloxi ® 68 DPX Survivac 68 PRN FDA Approves 68 balsalazide disodium Capsules 68 ® bortezomib 68 Aganocide ® 68 TransVax TM 68 Telbivudine 68 candesartan cilexetil 68 PROVENGE ® 68 MT#/MEDI-# 68 MCSP respectively 68 combines bupropion 68 Tesamorelin 68 Mg Uk 68 Voreloxin 68 modulator SERM 68 ketolide antibiotic 68 Vascular Disrupting Agent 68 MGd 68 drug ISA# 68 myelofibrosis polycythemia vera 68 Nasdaq TARG 68 ocular formulation 68 opioid induced constipation OIC 68 budesonide foam 68 PEGylated interferon beta 1a 68 pediatric acute lymphoblastic 68 cromolyn sodium 68 Response Genetics Inc. 68 Pharmacokinetics PK 68 GW# [003] 68 Tibotec Therapeutics division 68 ADVEXIN p# therapy 68 Mipomersen 68 neovascular diseases 68 NPC 1C 68 fosbretabulin 68 ELACYT 68 Hormone Refractory Prostate Cancer 68 Nasdaq ACHN 68 BRILINTA 68 cMET 68 Pimavanserin 68 Alvine Pharmaceuticals 68 Therapeutic Vaccine 68 INCB# [001] 68 Adenosine Therapeutics 68 oritavancin semi 68 NP2 Enkephalin 68 Phase III multicenter 68 lomitapide 68 developing Zerenex ferric 68 Neutrolin ® 68 Aradigm Corporation 68 Biomarker Study 68 multi kinase inhibitor 68 Rexahn Pharmaceuticals 68 Nasdaq SGEN 68 Marqibo TM 68 DU #b 68 Acute Ischemic Stroke 68 polymerase inhibitor 68 Myrexis Inc. 68 subcutaneous formulation 68 Provectus Pharmaceuticals specializes 68 PSMA ADC 68 Ofatumumab 68 aripiprazole Abilify 68 Pertuzumab 68 miconazole Lauriad 68 adrenergic regulation 68 ILUVIEN ® 68 Kit CD# positive 68 Saforis 68 faropenem medoxomil 68 LUNESTA TM 68 OHR/AVR# 68 Polymer Microspheres 68 AMEX DDD 68 Tumour Vascular Disrupting Agent 68 OTCBB NPHC 68 candidates bavituximab